Comanche Biopharma
Mike Young is the current Co-Founder & President of Comanche Biopharma, with a strong background in program management, healthcare provider strategy, and organizational development. With experience at Novartis, The Medicines Company, Intercept Pharmaceuticals, and Massachusetts General Hospital, Mike has a proven track record of leadership in the healthcare industry. Mike holds certifications in program and project management from Stanford University Graduate School of Business and in leading and building a culture of innovation from Harvard Business School Executive Education.
Comanche Biopharma
2 followers
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.